Literatur
-
1
Raspe H, Conrad S, Muche-Borowski C.
Evidenzbasierte und interdisziplinär konsentierte Versorgungspfade für Patientinnen/Patienten mit Morbus Crohn oder Colitis ulcerosa.
Z Gastroenterol.
2009;
47
541-562
-
2
Preiß J C, Schneidereit O, Höhne W. et al .
Status der ambulanten Versorgung von Patienten mit chronisch entzündlichen Darmerkrankungen.
Z Gastroenterol.
2008;
47 (9)
P004
-
3
Blumenstein I, Bock H, Weber C. et al .
Health Care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany; a multicenter, prospective, internet based study.
Inflamm Bowel Dis.
2008;
14
53-60
-
4
Wallace T M, Veldhuyzen van Zanten S J.
Frequency of use and standards of care for the use of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease: a systematic review of the literature and a survey of Canadian gastroenterologists.
Can J Gastroenterol.
2001;
15
21-28
-
5
Rubin G, Hungin A PS, Chinn D. et al .
Long-term aminosalicylate therapy is under-used in patients with ulcerative colitis: a cross-sectional survey.
Aliment Pharmacol Ther.
2002;
16
1889-1893
-
6
Gearry R B, Ajlouni Y, Nandurkar S. et al .
5-Aminosalicylic acid (mesalazine) use in Crohn’s disease: a survey of the opinions and practice of Australian gastroenterologists.
Inflamm Bowel Dis.
2007;
13
1009-1015
-
7
Yip J S, Woodward M, Abreu M T. et al .
How are Azathioprine and 6-mercaptopurine dosed by gastroenterologists? Results of a survey of clinical practice.
Inflamm Bowel Dis.
2008;
14
514-518
-
8
Parkes J, Roderick P, Bennett-Lloyd B. et al .
Variation in Hepatitis C services may lead to inequity of health-care provision: a survey of the organisation and delivery of services in the United Kingdom.
BMC Public Health.
2006;
6
3
Prof. Dr. Martin Zeitz
Medizinische Klinik I (Gastroenterologie/Infektiologie/Rheumatologie), Charité – Universitätsmedizin Berlin, Campus Benjamin Franklin
Hindenburgdamm 30
12200 Berlin
Phone: ++ 49/30/84 45 23 47
Fax: ++ 49/30/84 45 44 81
Email: gastro.cbf@charite.de
